# Pompe Pregnancy Sub-Registry

> **NCT00567073** · — · RECRUITING · sponsor: **Genzyme, a Sanofi Company** · enrollment: 20 (estimated)

## Conditions studied

- Glycogen Storage Disease Type II (GSD-II)
- Pompe Disease (Late-onset)
- Glycogenesis 2 Acid Maltase Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00567073
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2007-06-18
- **Primary completion:** 2034-01-31
- **Final completion:** 2034-01-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567073, "Pompe Pregnancy Sub-Registry". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00567073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*